Planet 13 Holdings (PLNH) Net Equity Issued and Repurchased (2024)
Planet 13 Holdings (PLNH) posted quarterly Net Equity Issued and Repurchased of -$1.0 for Q4 2024, up 100.0% quarter-over-quarter from -$51648.0 in Q2 2024.
Planet 13 Holdings (PLNH) Net Equity Issued and Repurchased (2024) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Net Equity Issued and Repurchased for 1 consecutive years, with -$1.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Net Equity Issued and Repurchased changed N/A year-over-year to -$1.0; the TTM figure through Sep 2025 stood at -$1.0 (down 100.0% YoY), while the FY2024 annual figure was $9.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased rose to -$1.0 in Q4 2024 per PLNH's latest filing, from -$51648.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.9 million in Q1 2024 and bottomed at -$51648.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Jun 30, 2024 | -51,648.00 |
| Jun 30, 2024 | -51,648.00 |
| Mar 31, 2024 | 9.91 Mn |
| Mar 31, 2024 | 9.91 Mn |